Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies; New Report Launched
Cystic fibrosis therapies will push Vertex ahead of GSK in $46.6 billion respiratory market by 2022, says Publisher
View full press release